PublizoomAward notice Supplies
Raamovereenkomst voor de levering van Xofigo
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- AZ Sint-Lucas Brugge vzw
Brugge - Place of performance
- 8310 Brugge, West Flanders
- Amount awarded
- €336,258 excl. VAT
- Planned end of contract
- 30 April 2027
likely re-tender around October 2026 - Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- oth-single
- Publication
- 12 May 2025
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Voorwerp van deze levering: Xofigo Het betreft een raamovereenkomst voor 2 jaar, en is 2 maal verlengbaar: Verlening 1: 12 maanden Verlenging 2: 12 maanden De verlenging gebeurt stilzwijgend, bij niet verlenging wordt dit minimum 1 maand voor vervaldatum van de opdracht door de aanbestedende overheid doorgegeven.
Awarded to
- BAYER NV BCE/KBO 0404.754.571
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Raamovereenkomst voor de levering van Bevacizumab AZ Sint-Lucas Brugge vzw · 1 August 2024 |
Biosimilar Collaborations Ireland Limited | €354,584 |
| Raamovereenkomst voor de levering van Sugammadex AZ Sint-Lucas Brugge vzw · 21 May 2024 |
SANDOZ | €71,155 |
| Raamovereenkomst voor de levering van Rituximab IV en Trastuzumab IV AZ Sint-Lucas Brugge vzw · 21 May 2024 |
SANDOZ Celltrion Healthcare Netherlands B.V. |
€59,115 |
| SUPPLEMENTS NUTRITIONNELS ORAUX (SNO) - hypercaloriques et hyperprotéinés, avec fibres Centre Hospitalier Régional de Huy · 23 October 2026 |
Fresenius Kabi | €259,714 |
| Luspatercept VITAZ vzw · 22 October 2026 |
Orifarm Belgium | €3,000,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 298316-2025.